trifluoperazine has been researched along with Cancer of Prostate in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Whereas the treatment of prostate cancer cells individually with anti-CaM drug or calcimycin, which increases intracellular Ca(++) and activates Cpn, led to minimal AR breakdown, combined treatment led to a precipitous decrease in AR protein levels." | 1.37 | Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. ( Bai, VU; Barrack, ER; Chinnakannu, K; Kim, SH; Menon, M; Murthy, S; Reddy, GP; Sivanandam, A, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sivanandam, A | 1 |
Murthy, S | 1 |
Chinnakannu, K | 1 |
Bai, VU | 1 |
Kim, SH | 1 |
Barrack, ER | 1 |
Menon, M | 1 |
Reddy, GP | 1 |
Batra, S | 1 |
Popper, LD | 1 |
Hartley-Asp, B | 1 |
2 other studies available for trifluoperazine and Cancer of Prostate
Article | Year |
---|---|
Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells.
Topics: Antineoplastic Agents; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin | 2011 |
Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Calmodulin; Cell Divisio | 1991 |